Skip to main content
Caplight Logo









Candesant Biomedical

Candesant Biomedical

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://candesant.com

Last Round

Debt

Mar 4, 2025

Total Funding Raised

$54.13M

Company Overview

Candesant Biomedical is a medical device company that develops non-invasive treatments for hyperhidrosis using its proprietary targeted alkali thermolysis technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Fashion & Beauty

Business Model

B2B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

hyperhidrosis treatmentsweat controlmedical deviceexcessive sweatingsweat reductiondermatologysweat patchaxillary hyperhidrosisaesthetic medicinenon-invasive treatmenttargeted sweat technologyTSTin-office procedureaesthetic dermatologysweat fix

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Candesant Biomedical Comparables

Compare Candesant Biomedical with similar companies based on industry and business-model similarity.

Candesant Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Botanix Pharmaceuticals Ltd
67%
Journey Medical Corp
66%
AbbVie
63%

Candesant Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMar 4, 2025
Series BJun 6, 2023
AcceleratorJun 22, 2020
Series AFeb 14, 2020

Candesant Biomedical Investors

Notable investors and investment history

Candesant Biomedical investors
InvestorRounds
KCK MedTechSeries B
MedTech InnovatorAccelerator
Horizon Technology Finance CorporationDebt
Polaris PartnersSeries B, Series A
Correlation VenturesSeries B
AstiaSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2025

    $10M debt round led by Horizon Technology Finance Corporation.

  • Jun 6, 2023

    $35M round led by KCK MedTech.

Candesant Biomedical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Candesant Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Candesant Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2016
Last FundingMar 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?